RECENT PLACEMENT

Occam Recruits Senior Pharma Executive to the Board of Geron

Occam Recruits Senior Pharma Executive to the Board of Geron

In March 2019, Occam Global placed Elizabeth G. O’Farrell on the Board of Geron Corporation, a publicly traded commercial-stage oncology biotech.  Liz brings over 24 years of experience as a senior executive of Eli Lilly and Company, recently serving as Chief Procurement Officer.  She is active on several boards, including Karius, Genmab, LENSAR, and PDL BioPharma.  

‍

Ms. O'Farrell holds a BS in accounting with honors and an MBA in Management Information Systems from Indiana University.

‍

Read more about Occam's work with Geron in our case study.

‍

Recent Placements

  1. Edith Hessel as CSO and Lindsay Edwards as CTO at Relation Therapeutics
  2. Dan Kemp as CEO of Shinobi Therapeutics
  3. Roy Larsen, PhD as CEO for RadioPharm Start-Up
  4. David Lynch as CBO at Strateos
  5. Craig Thompson as CEO at Cerevance
  6. Occam Recruits CSO for Public Gene Therapy Company, Adverum
  7. Occam Recruits Michael Miller to the Board of BioXcel
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.